Lamivudine therapy in patients undergoing liver transplantation for hepatitis b virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immu-Reference-Cited by-同舟云学术

Lamivudine therapy in patients undergoing liver transplantation for hepatitis b virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immu

Published:1999-11 Issue:6 Volume:5 Page:512-519
ISSN:1074-3022
Container-title:Liver Transplantation and Surgery
language:en
Short-container-title:Liver Transpl

Author:

McCaughan Geoffrey W.,Spencer Jenean,Koorey David,Bowden Scott,Bartholomeusz Angeline,Littlejohn Margaret,Verran Deborah,Chui Albert K.K.,Sheil A.G. Ross,Jones Robert M.,Locarnini Stephen A.,Angus Peter W.

Publisher

Wiley

Subject

Hepatology,Surgery

Reference35 articles.

1. Orthotopic liver transplantation for patients with hepatitis B virus-related disease;Todo;Hepatology,1991

2. Liver transplantation for patients with hepatitis B;Lake;What have we learned from our results? Hepatology,1991

3. Liver transplantation for hepatitis B virus-associated cirrhosis: A progress report;Van Thiel;Hepatology,1994

4. Impact of immunoprophylaxis and patient selection on outcome of transplantation for HBsAg-positive liver recipients;Devlin;J Hepatol,1994

5. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients;Samuel;Lancet,1991

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunoglobulin, nucleos(t)ide analogues and hepatitis B virus recurrence after liver transplant: A meta‐analysis;European Journal of Clinical Investigation;2021-05-03

2. Longterm outcome of the liver graft: A clinician's perspective-recurrent disease, the universal shifting;Liver Transplantation;2017-10

3. Simultaneous determination of entecavir and lamivudine in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study;RSC Advances;2016

4. High Genetic Barrier Nucleos(t)ide Analogue(s) for Prophylaxis From Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review;American Journal of Transplantation;2012-11-08

5. Anti-hepatitis B surface immunoglobulin reduction in early postoperative period after liver transplantation in hepatitis B virus-positive patients;Hepatology Research;2011-09-29